The mystery of evacetrapib - why are CETP inhibitors failing?

Stephen J. Nicholls; Kristen Bubb

doi:10.1080/14779072.2020.1745633

The mystery of evacetrapib - why are CETP inhibitors failing?

Research output: Contribution to journal › Editorial › Other › peer-review

Original language	English
Pages (from-to)	127-130
Number of pages	4
Journal	Expert Review of Cardiovascular Therapy
Volume	18
Issue number	3
DOIs	https://doi.org/10.1080/14779072.2020.1745633
Publication status	Published - 3 Mar 2020

Keywords

Atherosclerosis
CETP
lipids
prevention
risk factors

Access to Document

10.1080/14779072.2020.1745633

301913286-oaFinal published version, 664 KB

Link to publication in Scopus

Cite this

@article{5cc9d9be1cdc4398865cafcc6e63c390,

title = "The mystery of evacetrapib - why are CETP inhibitors failing?",

keywords = "Atherosclerosis, CETP, lipids, prevention, risk factors",

author = "Nicholls, {Stephen J.} and Kristen Bubb",

year = "2020",

month = mar,

day = "3",

doi = "10.1080/14779072.2020.1745633",

language = "English",

volume = "18",

pages = "127--130",

journal = "Expert Review of Cardiovascular Therapy",

issn = "1477-9072",